•
Jun 30, 2020

Cocrystal Pharma Q2 2020 Earnings Report

Total Revenue
$554K
Previous year: $592K
-6.4%
EPS
-$0.84
Previous year: -$0.05
+1580.0%
Gross Profit
$552K
Previous year: $591K
-6.6%
Cash and Equivalents
$19.3M
Free Cash Flow
-$2.33M
Previous year: -$1.03M
+125.5%
Total Assets
$40.5M
Previous year: $74.9M
-46.0%

Cocrystal Pharma

Cocrystal Pharma